What is the recommended treatment for a patient with strep laryngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Strep Laryngitis

Treat strep laryngitis with penicillin V (250 mg four times daily or 500 mg twice daily) or amoxicillin (50 mg/kg once daily, maximum 1000 mg) for a full 10 days, as these remain the drugs of choice due to their proven efficacy, narrow spectrum, safety profile, and low cost. 1, 2

Confirming the Diagnosis First

  • Document Group A Streptococcus (GAS) infection with either rapid antigen detection testing (RADT) or throat culture before initiating antibiotics, as clinical features alone cannot reliably distinguish bacterial from viral causes. 1, 3
  • Laryngitis typically presents with hoarseness, which is actually more suggestive of a viral etiology rather than streptococcal infection—GAS pharyngitis classically causes sore throat, fever, tonsillar exudate, and cervical adenitis, but not prominent hoarseness or cough. 1, 4
  • If hoarseness is the predominant symptom, consider that this may represent viral laryngitis rather than true streptococcal infection, and testing becomes even more critical before prescribing antibiotics. 1

First-Line Antibiotic Regimens

For patients without penicillin allergy:

  • Penicillin V: 250 mg four times daily OR 500 mg twice daily for 10 days (adolescents and adults). 1, 2
  • Amoxicillin: 50 mg/kg once daily (maximum 1000 mg) for 10 days is equally effective and often preferred due to once-daily dosing and better palatability. 1, 2
  • Intramuscular benzathine penicillin G as a single dose (600,000 units if <27 kg; 1,200,000 units if ≥27 kg) ensures compliance when adherence to oral therapy is uncertain. 1, 2

Treatment for Penicillin-Allergic Patients

The type of penicillin allergy determines which alternative is safest:

Non-Immediate (Non-Anaphylactic) Penicillin Allergy

  • First-generation cephalosporins are the preferred alternatives with strong, high-quality evidence. 1, 5
  • Cephalexin 500 mg orally twice daily for 10 days (adults) or 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days (children). 1, 5
  • Cefadroxil 1 gram orally once daily for 10 days (adults) or 30 mg/kg once daily (maximum 1 gram) for 10 days (children). 1, 5
  • The cross-reactivity risk with first-generation cephalosporins is only 0.1% in patients with non-severe, delayed penicillin reactions, making them very safe. 5

Immediate/Anaphylactic Penicillin Allergy

  • Patients with immediate hypersensitivity (anaphylaxis, angioedema, urticaria within 1 hour) must avoid ALL beta-lactam antibiotics, including cephalosporins, due to up to 10% cross-reactivity risk. 1, 5
  • Clindamycin 300 mg orally three times daily for 10 days (adults) or 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days (children) is the preferred alternative. 1, 5, 2
  • Clindamycin has only ~1% resistance among GAS in the United States and demonstrates high efficacy even in chronic carriers. 5, 2
  • Azithromycin 500 mg orally once daily for 5 days (adults) or 12 mg/kg once daily (maximum 500 mg) for 5 days (children) is an acceptable alternative. 1, 5
  • Clarithromycin 250 mg orally twice daily for 10 days (adults) or 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days (children) is also acceptable. 1, 5

Critical Treatment Duration Requirements

  • A full 10-day course is essential for ALL antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent acute rheumatic fever. 1, 5, 2
  • Azithromycin requires only 5 days due to its prolonged tissue half-life, making it the sole exception to the 10-day rule. 1, 5
  • Shortening the course by even a few days dramatically increases treatment failure rates and risk of acute rheumatic fever, even if symptoms resolve in 3-4 days. 5, 2

Important Resistance Considerations

  • Macrolide resistance (azithromycin, clarithromycin) among GAS is approximately 5-8% in the United States but varies geographically—some areas have much higher rates. 5, 4
  • Clindamycin resistance remains very low at approximately 1%, making it more reliable than macrolides when beta-lactams cannot be used. 5, 2
  • There is NO documented penicillin resistance in GAS anywhere in the world, which is why penicillin/amoxicillin remain first-line. 5

Common Pitfalls to Avoid

  • Do not use cephalosporins if the patient had anaphylaxis, angioedema, or immediate urticaria to penicillin—the 10% cross-reactivity risk is too high. 5
  • Do not prescribe broad-spectrum cephalosporins (cefdinir, cefixime, cefpodoxime) when narrow-spectrum first-generation agents (cephalexin, cefadroxil) are appropriate—they are more expensive and select for resistant flora. 5
  • Do not assume all penicillin-allergic patients need macrolides or clindamycin—most can safely receive first-generation cephalosporins if the allergy was non-immediate. 5
  • Do not prescribe shorter courses than recommended (except azithromycin's 5-day regimen)—this increases treatment failure and rheumatic fever risk. 5, 2

Adjunctive Symptomatic Treatment

  • Acetaminophen or NSAIDs (such as ibuprofen) should be considered for moderate to severe symptoms or high fever as adjunctive therapy. 1, 5
  • Aspirin must be avoided in children due to Reye syndrome risk. 1, 5
  • Corticosteroids are NOT recommended as adjunctive therapy. 1, 5

Post-Treatment Follow-Up

  • Routine follow-up throat cultures or RADT are NOT recommended for asymptomatic patients who have completed therapy. 1, 3
  • Patients become non-contagious after 24 hours of appropriate antibiotic therapy. 3
  • Reevaluate patients with worsening symptoms after appropriate antibiotic initiation or with symptoms lasting 5 days after starting treatment. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Group A Streptococcal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Concurrent Strep Pharyngitis and Infectious Mononucleosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Streptococcal Pharyngitis: Rapid Evidence Review.

American family physician, 2024

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.